Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2015 (2015), Article ID 176409, 14 pages
http://dx.doi.org/10.1155/2015/176409
Research Article

Bcl-xL Genetic Modification Enhanced the Therapeutic Efficacy of Mesenchymal Stem Cell Transplantation in the Treatment of Heart Infarction

1Department of Cardiovascular Surgery, General Hospital of Shenyang Military Area Command, Shenyang Northern Hospital, Wenhua Road No. 83, Shenhe District, Shenyang 110016, China
2Department of Cardiovascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi 710032, China

Received 19 August 2014; Revised 4 November 2014; Accepted 11 November 2014

Academic Editor: Sadia Mohsin

Copyright © 2015 Xiaodong Xue et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., “Multilineage potential of adult human mesenchymal stem cells,” Science, vol. 284, no. 5411, pp. 143–147, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Ferrari, G. Cusella-De Angelis, M. Coletta et al., “Muscle regeneration by bone marrow-derived myogenic progenitors,” Science, vol. 279, no. 5356, pp. 1528–1530, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Toma, M. F. Pittenger, K. S. Cahill, B. J. Byrne, and P. D. Kessler, “Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart,” Circulation, vol. 105, no. 1, pp. 93–98, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Piryaei, M. R. Valojerdi, M. Shahsavani, and H. Baharvand, “Differentiation of bone marrow-derived mesenchymal stem cells into hepatocyte-like cells on nanofibers and their transplantation into a carbon tetrachloride-induced liver fibrosis model,” Stem Cell Reviews and Reports, vol. 7, no. 1, pp. 103–118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Chen, Y. Li, L. Wang, M. Lu, X. Zhang, and M. Chopp, “Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats,” Journal of the Neurological Sciences, vol. 189, no. 1-2, pp. 49–57, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. J. M. Sorrell, M. A. Baber, and A. I. Caplan, “Influence of adult mesenchymal stem cells on in vitro vascular formation,” Tissue Engineering Part A, vol. 15, no. 7, pp. 1751–1761, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Pontikoglou, F. Deschaseaux, L. Sensebe, and H. A. Papadaki, “Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation,” Stem Cell Reviews and Reports, vol. 7, no. 3, pp. 569–589, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Djouad, P. Plence, C. Bony et al., “Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals,” Blood, vol. 102, no. 10, pp. 3837–3844, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Le Blanc, C. Tammik, K. Rosendahl, E. Zetterberg, and O. Ringdén, “HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells,” Experimental Hematology, vol. 31, no. 10, pp. 890–896, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Zhang, D. Methot, V. Poppa, Y. Fujio, K. Walsh, and C. E. Murry, “Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies,” Journal of Molecular and Cellular Cardiology, vol. 33, no. 5, pp. 907–921, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Fan, C. Lin, S. Zhuo et al., “Transplantation with survivin-engineered mesenchymal stem cells results in better prognosis in a rat model of myocardial infarction,” European Journal of Heart Failure, vol. 11, no. 11, pp. 1023–1030, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Li, N. Ma, L. L. Ong et al., “Bcl-2 engineered MSCs inhibited apoptosis and improved heart function,” Stem Cells, vol. 25, no. 8, pp. 2118–2127, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Huang, Y. Ito, M. Morikawa et al., “Bcl-xL gene transfer protects the heart against ischemia/reperfusion injury,” Biochemical and Biophysical Research Communications, vol. 311, no. 1, pp. 64–70, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Huang, K. Nakamura, Y. Ito et al., “Bcl-xL gene transfer inhibits Bax translocation and prolongs cardiac cold preservation time in rats,” Circulation, vol. 112, no. 1, pp. 76–83, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. Y.-J. Geng, “Molecular mechanisms for cardiovascular stem cell apoptosis and growth in the hearts with atherosclerotic coronary disease and ischemic heart failure,” Annals of the New York Academy of Sciences, vol. 1010, pp. 687–697, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. L. Tang, Y. Tang, Y. C. Zhang, K. Qian, L. Shen, and M. I. Phillips, “Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector,” Journal of the American College of Cardiology, vol. 46, no. 7, pp. 1339–1350, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. O. Ham, S. Y. Lee, and B. W. Song, “Modulation of Fas-Fas ligand interaction rehabilitates hypoxia-induced apoptosis of mesenchymal stem cells in ischemic myocardium niche,” Cell Transplantation. In press. View at Publisher · View at Google Scholar
  18. J. C. Reed, “Bcl-2 family proteins,” Oncogene, vol. 17, no. 25, pp. 3225–3236, 1998. View at Google Scholar · View at Scopus
  19. H. Bai, K. Chen, Y.-X. Gao et al., “Bcl-xL enhances single-cell survival and expansion of human embryonic stem cells without affecting self-renewal,” Stem Cell Research, vol. 8, no. 1, pp. 26–37, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Srinivasan, F. Li, A. Wong et al., “Bcl-x(L) functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells,” The Journal of Biological Chemistry, vol. 273, no. 8, pp. 4523–4529, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Liu, C. Liu, B. Sun et al., “Differentiation of rabbit bone mesenchymal stem cells into endothelial cells in vitro and promotion of defective bone regeneration in vivo,” Cell Biochemistry and Biophysics, vol. 68, no. 3, pp. 479–487, 2014. View at Google Scholar
  22. M. Gnecchi, H. He, O. D. Liang et al., “Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells,” Nature Medicine, vol. 11, no. 4, pp. 367–368, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. L. Tang, Q. Zhao, X. Qin et al., “Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction,” The Annals of Thoracic Surgery, vol. 80, no. 1, pp. 229–237, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. S. Yoon, A. Wecker, L. Heyd et al., “Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction,” Journal of Clinical Investigation, vol. 115, no. 2, pp. 326–338, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Takahashi, T.-S. Li, R. Suzuki et al., “Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury,” American Journal of Physiology: Heart and Circulatory Physiology, vol. 291, no. 2, pp. H886–H893, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. M. S. Täng, B. Redfors, M. Lindbom et al., “Importance of circulating IGF-1 for normal cardiac morphology, function and post infarction remodeling,” Growth Hormone and IGF Research, vol. 22, no. 6, pp. 206–211, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. J.-M. Tang, J.-N. Wang, L. Zhang et al., “VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart,” Cardiovascular Research, vol. 91, no. 3, pp. 402–411, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Tang, X. Gan, R. Cheheltani et al., “Targeted delivery of vascular endothelial growth factor improves stem cell therapy in a rat myocardial infarction model,” Nanomedicine: Nanotechnology, Biology, and Medicine, 2014. View at Publisher · View at Google Scholar
  29. A. Iervolino, D. Trisciuoglio, D. Ribatti et al., “Bcl-2 overexpression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity,” The FASEB Journal, vol. 16, no. 11, pp. 1453–1455, 2002. View at Google Scholar · View at Scopus
  30. D. del Bufalo, D. Trisciuoglio, M. Scarsella, U. Zangemeister-Wittke, and G. Zupi, “Treatment of melanoma cells with a bcl-2/bcl-xL antisense oligonucleotide induces antiangiogenic activity,” Oncogene, vol. 22, no. 52, pp. 8441–8447, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Yang, K. He, F. Zheng et al., “Over-expression of hypoxia-inducible factor-1 alpha in vitro protects the cardiac fibroblasts from hypoxia-induced apoptosis,” Journal of Cardiovascular Medicine, vol. 15, no. 7, pp. 579–586, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Fukuda, K. Hirota, F. Fan, Y. D. Jung, L. M. Ellis, and G. L. Semenza, “Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells,” Journal of Biological Chemistry, vol. 277, no. 41, pp. 38205–38211, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. H. D. Skinner, J. Z. Zheng, J. Fang, F. Agani, and B.-H. Jiang, “Vascular endothelial growth factor transcriptional activation is mediated by hypoxia-inducible factor 1α, HDM2, and p70S6K1 in response to phosphatidylinositol 3-kinase/AKT signaling,” The Journal of Biological Chemistry, vol. 279, no. 44, pp. 45643–45651, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. N. Chen, X. Chen, R. Huang et al., “BCL-xL is a target gene regulated by hypoxia-inducible factor-1α,” The Journal of Biological Chemistry, vol. 284, no. 15, pp. 10004–10012, 2009. View at Publisher · View at Google Scholar · View at Scopus